Literature DB >> 28699769

Deriving more value from RWE to ensure timely access of medicines by patients.

Sarah Wamala Andersson1, Mattias Kyhlstedt2.   

Abstract

Entities:  

Keywords:  comparative effectiveness research; evidence-based medicine; health technology assessment

Mesh：

Year:  2017        PMID： 28699769     DOI： 10.2217/cer-2017-0030

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN： 2042-6305            Impact factor:   1.744


× No keyword cloud information.
  2 in total

1.  Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?

Authors:  Sajan Khosla; Robert White; Jesús Medina; Mario Ouwens; Cathy Emmas; Tim Koder; Gary Male; Sandra Leonard
Journal:  F1000Res       Date:  2018-01-25

2.  Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Authors:  Kelvin Chan; Seungree Nam; Bill Evans; Claire de Oliveira; Alexandra Chambers; Scott Gavura; Jeffrey Hoch; Rebecca E Mercer; Wei Fang Dai; Jaclyn Beca; Mina Tadrous; Wanrudee Isaranuwatchai
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.